Variation in TCF7L2 Influences Therapeutic Response to Sulfonylureas
A GoDARTs Study
Article Information
vol. 56 no. 8 2178-2182
PubMed
Published By
Print ISSN
Online ISSN
History
- Received March 30, 2007
- Accepted May 18, 2007
- Published in print July 27, 2007.
- Published online ahead of print May 22, 2007.
Article Versions
- Previous version (May 22, 2007 - 13:23).
- You are viewing the most recent version of this article.
Copyright & Usage
DIABETES
Author Information
- Ewan R. Pearson1,
- Louise A. Donnelly2,
- Charlotte Kimber3,
- Adrian Whitley3,
- Alex S.F. Doney1,
- Mark I. McCarthy4,
- Andrew T. Hattersley5,
- Andrew D. Morris1 and
- Colin N.A. Palmer3
- 1Division of Medicine and Therapeutics, University of Dundee, Dundee, U.K
- 2Health Informatics Centre, University of Dundee, Dundee, U.K
- 3Population Pharmacogenetics Group, Biomedical Research Centre, University of Dundee, Dundee, U.K
- 4Oxford Centre for Diabetes, Endocrinology and Metabolism, Oxford, U.K
- 5Institute of Biomedical Sciences, Peninsula Medical School, Plymouth, U.K
- Address correspondence and reprint requests to Ewan Pearson, Division of Medicine and Therapeutics, Ninewells Hospital and Medical School, Ninewells Avenue, Dundee, DD1 9SY, U.K. E-mail: e.pearson{at}chs.dundee.ac.uk